A new population-based cohort study published in Primary Care Diabetes examined the quality of primary care for type 2 diabetes (T2D) among migrants and non-migrants in the Netherlands using 2015–2019 data from the DIAMANT cohort, linked to Statistics Netherlands.
Researchers found that most migrant groups were monitored for T2D parameters (HbA1c, systolic blood pressure, LDL cholesterol) as often – or more often – than non-migrants. However, migrants were less likely to achieve HbA1c treatment targets, with Turkish migrants showing the lowest odds (OR 0.61). Exploratory analyses suggest that less frequent insulin prescribing to migrants may partly explain these differences.
The study highlights the need for tailored approaches to address barriers in glycaemic control, including potential differences in treatment intensification, lifestyle support, and patient–provider communication.
Key highlights:
- Migrants generally receive equal or better annual T2D monitoring than non-migrants
- HbA1c targets are met less often among migrants, despite similar monitoring rates
- Insulin is prescribed less frequently to migrants not meeting glycaemic targets
Read the full article now, available open access
via Primary Care Diabetes:
